Solana Co — Director's Dealing 2016

Apr 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2016-04-18

Reporting Person: LaViscount Joyce N (CFO and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-18	Class A Common Stock, Without Par Value	A	50224	—	Acquired	50224	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-18	Warrant	$	A	25112	Acquired	2019-04-18	Class A Common Stock (25112)	Direct

Footnotes

F1: The reported securities are included within 50,224 Units purchased by the reporting person for $.77 per Unit. Each Unit consists of one share of common stock and one half warrant. Each full warrant gives the holder the right to purchase one share of common stock. Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.3047 on April 1, 2016, based on a price of CAD$1.00.

F2: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.3047 on April 1, 2016, based on a warrant exercise price of CAD$1.50.